---
figid: PMC9231089__pharmaceutics-14-01264-g015
pmcid: PMC9231089
image_filename: pharmaceutics-14-01264-g015.jpg
figure_link: /pmc/articles/PMC9231089/figure/pharmaceutics-14-01264-f015/
number: Figure 15
figure_title: ''
caption: Mechanisms involved in sorafenib chemosensitization by caryophyllane sesquiterpenes.
  (1) β-Caryophyllene and β-caryophyllene oxide modulate Pgp expression through the
  inhibition of STAT3 signaling, which is involved in MDR1 gene overexpression in
  different cancer cells. (2) Caryophyllane sesquiterpenes can affect MRP1 and MRP2
  expression likely by MAPK/ERK pathway, although the exact mechanism deserves further
  investigation. (3) β-Caryophyllene and β-caryophyllene oxide can directly inhibit
  Pgp and MRP1/2 pumps.
article_title: 'Sorafenib Chemosensitization by Caryophyllane Sesquiterpenes in Liver,
  Biliary, and Pancreatic Cancer Cells: The Role of STAT3/ABC Transporter Axis.'
citation: Silvia Di Giacomo, et al. Pharmaceutics. 2022 Jun;14(6):1264.
year: '2022'

doi: 10.3390/pharmaceutics14061264
journal_title: Pharmaceutics
journal_nlm_ta: Pharmaceutics
publisher_name: MDPI

keywords:
- β-caryophyllene
- β-caryophyllene oxide
- hepatocarcinoma
- pancreatic cancer
- cholangiocarcinoma
- potentiation
- sorafenib
- ABC transporters
- STAT3
- chemoresistance

---
